日本免疫规划进展与挑战:超越「疫苗鸿沟」
本文综述日本免疫规划近年进展:2015年3月消除麻疹、2015年10月将水痘疫苗纳入国家免疫规划、2016年10月将乙型肝炎病毒疫苗纳入国家免疫规划,正在缩小「疫苗鸿沟」。但仍面临人乳头瘤病毒疫苗积极推荐暂停未决、腮腺炎和轮状病毒疫苗未纳入国家免疫规划、强制国产疫苗短缺等问题,需持续采取新举措。
要点
- 2015年3月日本消除麻疹,2015年10月水痘疫苗、2016年10月乙型肝炎病毒疫苗纳入国家免疫规划。
- 2013年政府暂停人乳头瘤病毒疫苗的积极推荐,虽有新科学证据确认其安全性,暂停状态持续未解决。
- 腮腺炎和轮状病毒疫苗等自愿接种疫苗引入日本后未纳入国家免疫规划;自然灾害致疫苗工厂所在地区强制国产疫苗短缺。
核心结论
- 日本免疫规划近年取得显著进展,正在缩小「疫苗鸿沟」,即日本免疫规划相对于其他发达国家规划的延迟。
- 重要问题仍存:人乳头瘤病毒疫苗积极推荐自2013年暂停后持续未解决;腮腺炎和轮状病毒疫苗未纳入国家免疫规划;强制国产疫苗短缺及生产记录造假等问题。
- 需储备必需疫苗并讨论未来儿童疫苗需求,持续采取新举措缩小疫苗鸿沟,以保护日本儿童免受疫苗可预防疾病威胁。
研究设计与样本
- 本文为综述,围绕日本免疫规划进展与挑战进行论述,未报告检索范围。
主要发现
- 2014年以来主要进展包括:2015年3月消除麻疹;2015年10月将水痘疫苗作为常规免疫纳入国家免疫规划;2016年10月将乙型肝炎病毒疫苗作为常规免疫纳入国家免疫规划。
- 2013年政府暂停人乳头瘤病毒疫苗的积极推荐,该暂停持续且未解决,尽管有新科学证据确认这些疫苗的安全性。
- 腮腺炎和轮状病毒疫苗等重要自愿接种疫苗自引入日本后未纳入国家免疫规划。
- 疫苗生产工厂所在地区发生自然灾害导致强制国产疫苗短缺;此外,生产商在某些疫苗产品中加入未经批准的添加剂并伪造生产流程记录。
临床怎么用
- 为避免疫苗短缺相关问题,需储备必需疫苗,并讨论未来儿童疫苗需求。
- 需持续采取新举措缩小疫苗鸿沟,以保护日本儿童免受疫苗可预防疾病威胁。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Japanese immunization program has made considerable recent progress. The introduction of several new vaccines, especially foreign-produced vaccines, and the inclusion of important new vaccines in the National Immunization Program (NIP) are closing the "vaccine gap", i.e., the delay in the Japanese immunization program relative to programs in other developed countries. Major progress in the Japanese immunization program since 2014 includes (1) elimination of measles in March 2015, (2) introduction of a varicella vaccine as a routine immunization in the NIP in October 2015, and (3) introduction of hepatitis B virus vaccines as routine immunizations in the NIP in October 2016. Despite these promising developments, important issues remain. First, the government withdrew the active recommendation for human papilloma virus vaccines temporarily in 2013. The withdrawal has continued and unresolved despite new scientific evidence confirming the safety of these vaccines. Second, a few important voluntary vaccines, including vaccines for mumps and rotavirus, have not been included in the NIP since their introduction to Japan. Finally, there are concerns related to a shortage of mandatory domestic vaccines, which was caused by a natural disaster in the area where a vaccine-producing factory was located. Additionally, the manufacturer included unauthorized additives in some vaccine products with falsifying the production-process records. To avoid problems related to vaccine shortages, essential vaccines need to be stockpiled, and the future vaccine needs for children should to be discussed. New initiatives must continue to close the vaccine gap, as this will protect children living in Japan from vaccine-preventable diseases.
引用
- Saitoh A, Okabe N. Progress and challenges for the Japanese immunization program: Beyond the "vaccine gap". Vaccine. 2018. PMID: 29929825. doi:10.1016/j.vaccine.2018.01.092
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。